Cargando…
Molecular Mechanisms of Antiviral Agents against Dengue Virus
Dengue is a major global health threat causing 390 million dengue infections and 25,000 deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of a clinically approved antiviral against dengue virus (DENV) drive the urgent demand for the development of novel anti-DEN...
Autores principales: | Lee, Michelle Felicia, Wu, Yuan Seng, Poh, Chit Laa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056858/ https://www.ncbi.nlm.nih.gov/pubmed/36992414 http://dx.doi.org/10.3390/v15030705 |
Ejemplares similares
-
Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus
por: Anasir, Mohd Ishtiaq, et al.
Publicado: (2020) -
Peptides as Therapeutic Agents for Dengue Virus
por: Chew, Miaw-Fang, et al.
Publicado: (2017) -
The Conserved Molecular Determinants of Virulence in Dengue Virus
por: Ahmad, Zuleeza, et al.
Publicado: (2019) -
Antiviral activity of silymarin and baicalein against dengue virus
por: Low, Zhao Xuan, et al.
Publicado: (2021) -
Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)